Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Korea"

138 News Found

KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


World’s first Donepezil patch to treat Alzheimer approved in South Korea
Biotech | November 17, 2021

World’s first Donepezil patch to treat Alzheimer approved in South Korea

Launching in 2022, its availability will be expanded to the global market


IOL receives Korean FDA approval
Drug Approval | October 14, 2021

IOL receives Korean FDA approval

The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead


Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery
Biopharma | January 23, 2026

Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery

This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market


GCCL and OPIS forge global clinical trial alliance
Clinical Trials | January 17, 2026

GCCL and OPIS forge global clinical trial alliance

GCCL aims to leverage the partnership to expand strategic relationships with global CROs


Redesigned brain receptor drugs show promise for depression
R&D | January 16, 2026

Redesigned brain receptor drugs show promise for depression

The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold


Nxera secures exclusive APAC rights to DMD drug Vamorolone in deal with Santhera
News | January 11, 2026

Nxera secures exclusive APAC rights to DMD drug Vamorolone in deal with Santhera

Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories


SN Bioscience’s SNB-101 wins FDA orphan drug designation for gastric cancer
Clinical Trials | December 29, 2025

SN Bioscience’s SNB-101 wins FDA orphan drug designation for gastric cancer

The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38


CPHI & PMEC India 2025 ignites pharma innovation and partnerships
News | December 29, 2025

CPHI & PMEC India 2025 ignites pharma innovation and partnerships

For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows